Helmholtz Zentrum München

Identification of a ferroptosis suppressor protein allows for new anticancer treatment approach

Discovery of potential novel therapeutic target for non-alcoholic fatty liver disease

BART-Seq: A Novel Method to Characterize Genes with High-Precision in Single Cells

The analysis of gene products in cells is an important tool for diagnosing disease and the design of new active substances in biological and medical research. At Helmholtz Zentrum München, a method of targeted RNA sequencing (transcriptome analysis) has now been developed, which precisely detects the smallest amounts of gene transcripts in single cells. The method ...

2

Specific identification of chronic lung disease in premature babies

What the wheat genome tells us about wars

Pluripotency or differentiation - that is the question

RNA Transport in Neurons - Staufen2 detects its target transcripts in a complex manner

2

CD30 - from witness to culprit

New machine learning model describes dynamics of cell development

From their birth through to their death, cells lead an eventful existence. Thanks to single-cell genomics, their destiny in large cell populations can now be analyzed. However, this method destroys the cell, which makes it difficult to draw conclusions about the dynamics of cell ...

Tackling Big Data - new graduate school for Data Science in Munich

As a result of digitalization, research is producing ever larger and more complex data sets. While these hold great potential for example for biomedicine, energy research, geo-research or robotics, they also need to be managed and interpreted. To address this need, the Munich School for Data Science @ Helmholtz, TUM & LMU (MuDS) has ...

Two-pronged approach - Novel combined therapy tackles excess fatty tissue

A new combined therapy for obesity and diabetes has been shown to suppress the appetite and at the same time increase energy expenditure. Scientists from the Helmholtz Zentrum München and the Technical University of Munich (TUM), partner institutions of the German Center for ...

Satiety in 3D

Many overweight people lack the feeling of being full. It was long thought that this was due to the disrupted transport of the satiety hormone leptin to the brain. That is not the case, as a group of scientists from Helmholtz Zentrum München has now shown in the 'International Journal of Obesity'. The work was made possible by a new 3D imaging technique that allows tracking the path ...